Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-125,406
Closed -$26.6M 437
2021
Q4
$26.6M Buy
125,406
+707
+0.6% +$139K 0.88% 31
2021
Q3
$18.8M Buy
124,699
+2,649
+2% +$388K 0.73% 45
2021
Q2
$17.7M Buy
122,050
+7,154
+6% +$909K 0.68% 49
2021
Q1
$14.2M Buy
114,896
+4,222
+4% +$563K 0.61% 55
2020
Q4
$15.7M Buy
110,674
+1,406
+1% +$183K 0.73% 44
2020
Q3
$11.4M Buy
109,268
+5,142
+5% +$528K 0.59% 54
2020
Q2
$10.2M Buy
104,126
+16,786
+19% +$1.49M 0.58% 51
2020
Q1
$6.81M Buy
+87,340
New +$7.61M 0.47% 63

Other funds holding XLNX

Glenview Trust's XLNX Position: Q1 2022 in Review

Glenview Trust sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 125,406 shares — an estimated $26.6M sold.

Glenview Trust first reported a position in XLNX in Q1 2020 and held it in 8 quarters. The position peaked at $26.6M in Q4 2021. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

  • Glenview Trust reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
  • Glenview Trust sold 125,406 Xilinx Inc shares in Q1 2022, an estimated $26.6M.
  • Glenview Trust first reported a position in Xilinx Inc in Q1 2020 and held it in 8 quarters.
  • Glenview Trust's Xilinx Inc position peaked at $26.6M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on Glenview Trust's 13F filing for Q1 2022, filed 11 May 2022.